z-logo
open-access-imgOpen Access
Integrated Disease Control Initiatives: Polio Eradication and Neonatal Tetanus Elimination in Egypt
Author(s) -
Esmat Mansour,
Aylward Rb,
Frank E. Cummings
Publication year - 1997
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/175.supplement_1.s277
Subject(s) - poliomyelitis eradication , poliomyelitis , disease eradication , tetanus , medicine , neonatal tetanus , immunization , public health , environmental health , toxoid , disease , vaccination , polio vaccination , disease control , pediatrics , poliovirus , virology , immunology , nursing , virus , pathology , antigen
Accelerated disease control initiatives, such as polio eradication by the year 2000, may substantially benefit public health programs in general. In Egypt, the control of other vaccine-preventable diseases, most noticeably neonatal tetanus (NT), has been facilitated by the polio eradication initiative. Linking NT reporting with the acute flaccid paralysis (AFP) surveillance system, which had been established for polio eradication, markedly improved the capacity to identify NT high-risk areas and target supplementary immunization activities appropriately. While the close integration of surveillance activities was to the benefit of both programs, mass immunization activities were not conducted simultaneously because of differences in the objectives, target populations, and operational aspects of oral polio vaccine and tetanus toxoid campaigns. In addition to substantial progress toward polio eradication in Egypt since 1988, there has been an 80% reduction in annual NT cases, in part due to the integration of appropriate aspects of these two disease control initiatives.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here